Pinar Kanlikilicer, Ph.D.
Mesothelioma.net content reviewer and editor
- PhD in Biomedical Engineering from the University of Houston
- Completed a fellowship at the Experimental Therapeutics Department, MD Anderson Cancer Center
- Worked as a research faculty member in the same department
- Currently at the Cancer Prevention Department, MD Anderson Cancer Center
Dr. Kanlikilicer is currently a senior clinical scientist in neurology late development at Sanofi. She was previously a biomedical engineer working in the Cancer Prevention Department at MD Anderson Cancer Center in Houston.[1]
Dr. Kanlikilicer has more than 10 years of experience in clinical research and drug development. She completed five years of postdoctoral training in the Department of Experimental Therapeutics at MD Anderson and now researches tumor microenvironments, the role of small non-coding RNAs in cellular communication, and the development of RNA-based therapeutics for cancer patients.
Experience
After she completed her training at MD Anderson Cancer Center – #1 for cancer care by the U.S. News & World Report annual “Best Hospitals” survey Dr. Kanlikilicer started working as a research faculty member in the same department.
She has given many talks on the effect of the tumor microenvironment on the progression of ovarian cancer. She presented her research at the annual American Association for Cancer Research (AACR) meeting.
References
- LinkedIn. (n.d.). Pinar Kanlikilicer, PhD.
Retrieved from: https://www.linkedin.com/in/pinarknlk/